文献速递青光眼白内障与屈光手术

原发性闭角型青光眼晶状体摘除术后长期眼压控制的预测因素:EAGLE 试验结果

Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial.
PubMed 文献 · Br J Ophthalmol · 2022-04-06

基于 EAGLE 试验的二次分析,纳入 369 例完成 36 个月随访的原发性闭角型疾病患者,评估透明晶状体摘除(CLE)或激光周边虹膜切开术(LPI)后长期眼压控制的基线预测因素。CLE 组 90% 达到良好应答标准、66% 达到最佳应答标准,LPI 组分别为 67% 和 18%。随机分配至 CLE、中国籍、随机化前未使用青光眼滴眼液者更可能维持长期最佳眼压应答。

要点

  • CLE 组 36 个月良好应答 90%、最佳应答 66%,LPI 组分别为 67%、18%。
  • CLE 组维持最佳眼压应答的 OR=10.1(6.1 至 16.8)。
  • 中国籍 OR=2.3(1.3 至 3.9)、未用过青光眼滴眼液 OR=2.8(1.6 至 4.8)与更佳长期应答相关。

核心结论

  • 原发性闭角型青光眼/原发性闭角患者初始 CLE 手术后维持无滴眼液良好眼压控制的可能性约为 LPI 的 10 倍。
  • 非中国籍、较高基线眼压和随机化前使用青光眼滴眼液是长期眼压应答较差的预测因素。

研究设计与样本

  • 本研究为 EAGLE 试验数据的二次分析,共 369 例患者完成 36 个月随访检查,其中 CLE 组 182 例、LPI 组 187 例。
  • 主要分析采用多变量 logistic 回归模型评估随机化干预与眼部参数对治疗应答的预测作用。
  • 良好应答定义为眼压<21 mm Hg 且无需额外手术,最佳应答定义为在此基础上 additionally 无用药,均于 36 个月随访时评定。

主要发现

  • CLE 组 90% 达到良好应答标准,LPI 组为 67%;CLE 组 66% 达到最佳应答标准,LPI 组为 18%。
  • CLE 组无滴眼液/无手术生存时间显著更长(p<0.05)。
  • 随机分配至 CLE 者维持 36 个月长期最佳眼压应答的 OR=10.1(6.1 至 16.8)。
  • 中国籍者维持长期最佳眼压应答的 OR=2.3(1.3 至 3.9)。
  • 随机化前未使用青光眼滴眼液者维持长期最佳眼压应答的 OR=2.8(1.6 至 4.8)。

关键数值与推荐

  • 良好应答:36 个月随访时眼压<21 mm Hg 且无需额外手术。
  • 最佳应答:在良好应答基础上 additionally 无用药。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To assess baseline ocular parameters in the prediction of long-term intraocular pressure (IOP) control after clear lens extraction (CLE) or laser peripheral iridotomy (LPI) in patients with primary angle closure (PAC) disease using data from the Effectiveness of Early Lens Extraction for the treatment of primary angle-closure glaucoma (EAGLE) tria. METHODS: This study is a secondary analysis of EAGLE data where we define the primary outcome of 'good responders' as those with IOP<21 mm Hg without requiring additional surgery and 'optimal responders' as those who in addition were medication free, at 36-month follow-up. Primary analysis was conducted using a multivariate logistic regression model to assess how randomised interventions and ocular parameters predict treatment response. RESULTS: A total of 369 patients (182 in CLE arm and 187 in LPI arm) completed the 36-month follow-up examination. After CLE, 90% met our predefined 'good response' criterion compared with 67% in the LPI arm, and 66% met 'optimal response' criterion compared with 18% in the LPI arm, with significantly longer drops/surgery-free survival time (p<0.05 for all). Patients randomised to CLE (OR=10.1 (6.1 to 16.8)), Chinese (OR=2.3 (1.3 to 3.9)), and those who had not previously used glaucoma drops (OR=2.8 (1.6 to 4.8)) were more likely to maintain long-term optimal IOP response over 36 months. CONCLUSION: Patients with primary angle closure glaucoma/PAC are 10 times more likely to maintain drop-free good IOP control with initial CLE surgery than LPI. Non-Chinese ethnicity, higher baseline IOP and using glaucoma drops prior to randomisation are predictors of worse long-term IOP response.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mitchell WG, Azuara-Blanco A, Foster PJ, et al. Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial. Br J Ophthalmol. 2022. PMID: 35387778. doi:10.1136/bjophthalmol-2021-319765

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。